Union Bank of India is an operating-leverage story in a public-sector bank: a large, low-yielding legacy balance sheet is being re-mixed toward higher-yielding RAM and better-rated corporate credit while the funding base is shifted from bulk deposits to CASA and retail term deposits. The Q2 FY27 result shows the mechanism is now visible. Global advances grew 18.53% YoY and domestic advances 17.36%, while deposits grew 6.88%; NIM rose to 2.86% from 2.80% in Q1 and 2.64% in Q4 FY26, above the FY25-26 level of 2.70%; net profit rose 30.31% YoY to INR 5,537 crore and operating profit 18.99% to INR 8,108 crore. ROA was 1.38% and ROE 17.21%. The bank says it will grow 'as per the system credit growth' rather than repeating the earlier 13-14% FY27 target, and it holds over INR 1,00,000 crore of sanctioned but undisbursed large-corporate loans, mainly infrastructure, expected to disburse over the next 1.5 years, plus INR 64,000-68,000 crore of proposals in the sanction pipeline. That is guidance and pipeline disclosure, not a guarantee.
The economics work if the funding mix keeps improving. CASA was 35% in Q2 FY27, up from 32.56% a year earlier; CASA plus retail term deposits rose 11.41% YoY to INR 1.11 lakh crore and were 80.3% of deposits. The bank also secured USD 2.25 billion of FCNR deposits, above its USD 2 billion aim, and issued a USD 600 million foreign currency bond listed on Gift City NSE, with an MTN programme it can expand in USD 200-300 million batches. These are lower-cost or longer-term funding levers. The offset is that deposits still grew only 6.88% against 18.53% advance growth, and the global CD ratio was 88.13% (domestic around 84%). Management calls the domestic range comfortable at 80-84/85%, but the gap is the binding constraint on how long the current growth rate can run without re-entering bulk deposits.
Asset quality is supporting the earnings path. GNPA fell to 2.42%, NNPA to 0.42%, PCR was 95.20%, and credit cost was 21 bps in Q2 FY27. Gross slippages of INR 1,909 crore were more than covered by INR 3,086 crore of recoveries and upgradations, and the slippage ratio improved to 0.72%. The bank has a large written-off pool of INR 71,000 crore, with INR 45,000-46,000 crore in NCLT, but NCLT recoveries have 'more or less dried up,' so the recovery mix is shifting to OTS, SARFAESI and Lok Adalat. That is slower and less lumpy, and it is why the recovery run-rate matters as much as the gross NPA ratio.
The ECL transition is manageable but was badly communicated. In January 2026 management estimated a net ECL gap of INR 4,200-4,300 crore. In July 2026 it referred to a total requirement of INR 11,300 crore and a INR 6,000 crore residual. In Q2 FY27 it corrected the framing: the total transition impact is around INR 5,500 crore, against which it has set aside INR 1,000 crore, and a 70 bps CET impact would be absorbable within one quarter's profit. The recurring ECL credit cost has not been quantified. The relevant inference is that the one-time transition is smaller than the July headline suggested, but the market should not treat the absence of a recurring number as zero.
Capital allocation is conservative. CRAR was 17.94% and CET-1 16.05% in Q2 FY27, and LCR averaged 120%, 20 percentage points above the regulatory floor. The bank is not raising equity; it is using FCNR, foreign currency bonds, refinance and the treasury book to fund growth. The capital headroom supports the corporate pipeline, but it also means the bank can absorb ECL without dilution. The main capital-allocation question is whether the technology and process spend - a dated FY26 technology budget of INR 1,600 crore, Project Muskan's nine pillars with two completed including in-house Union Sudarshan, and RPA targets of about 200 processes by March 2027 and 400-500 by March 2028 - produces a lower cost-to-income ratio. The Q2 call did not disclose a new FY27 capex figure.
Management delivery is mixed. It delivered on NIM defense through the rate-cut cycle and on ROA above 1%, and it exceeded the FCNR target. It missed the FY25 growth guidance, withdrew FY26 growth guidance, and has now softened the FY27 credit-growth language from 13-14% to 'as per system.' It also revised the ECL number repeatedly. The PSLC promise of FY25-level income has not been restored: Q1 FY27 had INR 217 crore, Q2 had none, and management ties future sales to building the small and marginal farmer portfolio. These are not trivial, but they are communication and timing issues more than balance-sheet breakage.
The thesis falsifiers are specific. A sustained deposit growth rate below 8-10% while advances run above 15% would force bulk funding and pressure NIM. A fall in NIM below 2.80% without a fresh rate cut would break the margin trajectory. A rise in credit cost above 50 bps or a large corporate slippage from the new pipeline would challenge the asset-quality claim. A recurring ECL credit cost materially above the 20-40 bps range would absorb the operating leverage. And a failure to convert the corporate pipeline into disbursements over the next 1.5 years would leave the bank with the same low-growth problem it had in FY26. On current evidence, the operating-leverage thesis is intact but dependent on deposit mix and pipeline conversion, not on a re-rating of the sector.
companyname: Union Bank of India ticker: UNIONBANK sector: Banking / Financial Services Union Bank of India is a public sector bank founded in 1919 and headquartered in Mumbai. It operates 8,621 domestic branches (59% in rural and semi-urban centres), 8,910 ATMs, and over 23,500 Business Correspondents, with 73,900+ employees across 29 states and 5 Union Territories. The bank also runs 2 overseas branches (Sydney and Dubai DIFC), 5 wholly owned subsidiaries (including Union Bank of India (UK) L...
Read the full report →capex, margin expansion, new product segment, geographic expansion, order book surge
Q2 FY27 explicit forward guidance: advances to move in line with system credit growth; CASA and retail term deposits remain the funding priority; NIM to be defended and improved from the 2.86% Q2 level; ECL transition impact estimated at around INR 5,500 crore with INR 1,000 crore already buffered and the recurring ECL cost still being worked out; the over INR 1,00,000 crore large-corporate pipeline is expected to disburse over the next 1.5 years; RPA targets about 200 processes by March 2027 and 400-500 by March 2028.
Guidance maintainedconsistent
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Union Bank of India and 4,900+ companies.
5-day free pass. No card required.